Literature DB >> 26001872

Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.

Alice Ordean1, Meldon Kahan2, Lisa Graves3, Ron Abrahams4, Theresa Kim5.   

Abstract

OBJECTIVE: To describe obstetrical and neonatal outcomes including neonatal abstinence syndrome (NAS) in a Canadian cohort of methadone-maintained pregnant women.
METHODS: We conducted a retrospective chart review at three integrated care programs in Vancouver, Toronto, and Montreal. Pregnant women on methadone maintenance treatment (MMT) who attended for care between 1997 and 2009 were included in this multisite study. Maternal and neonatal outcomes in each of the three contributing centres were compared.
RESULTS: A total of 94 pregnant methadone-maintained women were included in the final analysis: 36 from Toronto, 36 from Vancouver, and 22 from Montreal. Maternal demographics showed inter-site differences in ethnicity and marital status. Obstetrical complications were not frequent; the most frequent was antenatal hemorrhage, which occurred in 14% of the total cohort. The incidence of premature labour was significantly higher in Vancouver and Montreal than in Toronto. The mean gestational age at delivery for the entire cohort was 38 weeks; mean birth weight was 2856 grams. The average length of hospital stay for babies with NAS was 19 days, with 27% of neonates requiring pharmacological treatment for NAS. Approximately 60% of neonates were discharged from hospital to the care of their mother.
CONCLUSION: Integrated care programs resulted in satisfactory obstetrical and neonatal outcomes for pregnant women on MMT. Policies promoting maternal-newborn contact, rooming-in, and breastfeeding may help to decrease the severity of NAS and the need for pharmacological treatment of NAS. We strongly recommend the development of similar programs across Canada to address gaps in services.

Entities:  

Keywords:  methadone; neonatal abstinence syndrome; pregnancy complications; prenatal care

Mesh:

Substances:

Year:  2015        PMID: 26001872     DOI: 10.1016/S1701-2163(15)30311-X

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  5 in total

1.  Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014.

Authors:  Tyler N A Winkelman; Nicole Villapiano; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-04       Impact factor: 7.124

2.  Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.

Authors:  Charlan D Kroelinger; Donna Addison; Mirelys Rodriguez; Marion E Rice; Meghan T Frey; Hadley R Hickner; Mary Kate Weber; Trish Mueller; Alisa Velonis; Keriann Uesugi; Lisa Romero; Sanaa Akbarali; Natalie Foster; Jean Y Ko; Ellen Pliska; Christine Mackie; Shanna Cox; S Nicole Fehrenbach; Wanda D Barfield
Journal:  J Womens Health (Larchmt)       Date:  2020-03-13       Impact factor: 2.681

3.  Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.

Authors:  Davida M Schiff; Elisha M Wachman; Barbara Philipp; Kathleen Joseph; Hira Shrestha; Elsie M Taveras; Margaret G K Parker
Journal:  Breastfeed Med       Date:  2018-04-09       Impact factor: 1.817

4.  Non-pharmacological care for opioid withdrawal in newborns.

Authors:  Adrienne Pahl; Leslie Young; Madge E Buus-Frank; Lenora Marcellus; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2020-12-21

Review 5.  Breastfeeding and Opiate Substitution Therapy: Starting to Understand Infant Feeding Choices.

Authors:  Lisa E Graves; Suzanne Turner; Maya Nader; Sucheta Sinha
Journal:  Subst Abuse       Date:  2016-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.